BioSpace News Archive

Job Trends

Superior HealthPlan Celebrates New Moms During National Women’s Health Week

Serving Texas women since 1999, Superior HealthPlan is proud to recognize National Women’s Health Week, May 12–18.

May 13, 2019
·
3 min read
Selvita to Present at the UBS 2019 Global Healthcare Conference in New York

Selvita announced that the company will present at the UBS Global Healthcare Conference, taking place on May 20-22 in New York.

May 13, 2019
·
1 min read
Drug Development

Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications

World’s highest field preclinical MRI will be used for oncology and neuroscience research

May 13, 2019
·
3 min read
Business

Novigenix Appoints Dr. Jan Groen as CEO to Lead Expansion to Multi-Product Cancer Diagnostic Platform Company

ImmunoTranscriptomic platform combines identification of immune cell mRNA signatures with AI for early cancer detection

May 13, 2019
·
4 min read
Genetown

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

$18.5 million in extension funding will support clinical pipeline of microbiome-derived product candidates

May 13, 2019
·
3 min read
Philogen Announces €62 Million Financing Round

€62M funding will be used to progress wholly-owned pipeline products through clinical development and expand manufacturing activities Dr. Guido Guidi, Dr. Roberto Ferraresi and Dr. Roberto Marsella join the board of directors

May 13, 2019
·
3 min read
4D Announces Participation in Neuro4D Conference, Frankfurt, Germany

4D pharma plc announces its participation in the Neuro4D conference, Frankfurt, Germany, 13-14 May, 2019.

May 13, 2019
·
3 min read
FDA

Lilly’s CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA® (ramucirumab injection, 10 mg/mL solution), as a single agent, for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) of ≥400 ng/mL and have been treated with sorafenib.

May 13, 2019
·
29 min read
Pharm Country

ITT to Present at the Goldman Sachs Industrials & Materials Conference 2019

ITT Inc. Chief Financial Officer Thomas Scalera will present at the Goldman Sachs Industrials & Materials Conference 2019 in New York City on Thursday, May 16.

May 13, 2019
·
1 min read
Policy

Anixa Biosciences Announces Completion of Cchek™ Analytical Verification at CLIA Laboratory

Anixa Biosciences, Inc. announced that its Cchek™ Prostate Cancer Confirmation test successfully passed all required initial analytical verification studies en route to commercialization and implementation in the ResearchDx facility.

May 13, 2019
·
3 min read